Otto Phanstiel Selected Research

dihydromotuporamine C

10/2017	Synthesis and Bioevaluation of Macrocycle-Polyamine Conjugates as Cell Migration Inhibitors.
5/2014	Synthesis and biological evaluation of antimetastatic agents predicated upon dihydromotuporamine C and its carbocyclic derivatives.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Otto Phanstiel Research Topics

Disease

17	Neoplasms (Cancer) 01/2022 - 01/2008
6	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2014
3	Adenocarcinoma 02/2022 - 01/2018
3	Leukemia 04/2013 - 06/2003
2	Melanoma (Melanoma, Malignant) 01/2021 - 07/2013
2	Experimental Melanoma 07/2008 - 08/2007
2	Leukemia L1210 07/2008 - 08/2007
1	Meningitis 12/2022
1	Sepsis (Septicemia) 12/2022
1	Pneumonia (Pneumonitis) 12/2022
1	Snyder Robinson syndrome 11/2021
1	Rare Diseases (Rare Disease) 11/2021
1	Neurocognitive Disorders (Clerambault Syndrome) 11/2021
1	Virus Diseases (Viral Diseases) 11/2021
1	Bacterial Infections (Bacterial Infection) 10/2019
1	Chagas Disease (American Trypanosomiasis) 03/2018
1	Starvation 10/2017
1	Atherosclerosis 06/2016
1	Pathologic Constriction (Stenosis) 06/2016
1	HIV Infections (HIV Infection) 01/2016
1	Neoplasm Metastasis (Metastasis) 05/2014
1	Breast Neoplasms (Breast Cancer) 07/2013
1	Malaria 06/2013
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 12/2009
1	Tuberculosis (Tuberculoses) 02/2008
1	Paratuberculosis (Johne's Disease) 09/2004

Drug/Important Bio-Agent (IBA)

24	PolyaminesIBA 02/2022 - 11/2004
5	Eflornithine (Ornidyl)FDA Link 01/2021 - 06/2003
5	Pharmaceutical PreparationsIBA 03/2018 - 01/2008
4	anthraceneIBA 01/2019 - 12/2009
3	SpermidineIBA 01/2021 - 08/2007
3	PutrescineIBA 01/2019 - 12/2009
2	5- iodo- 3- ((3,5- dibromo- 4- hydroxyphenyl)methylene)- 2- indolinoneIBA 12/2021 - 01/2021
2	SpermineIBA 11/2021 - 11/2021
2	LigandsIBA 01/2021 - 07/2013
2	dihydromotuporamine CIBA 10/2017 - 05/2014
2	Biological ProductsIBA 11/2004 - 06/2003
1	Capsules (Microcapsules)IBA 12/2022
1	Virulence Factors (Pathogenicity Factors)IBA 12/2022
1	human ATP13A3 proteinIBA 01/2022
1	P-type ATPasesIBA 01/2022
1	Messenger RNA (mRNA)IBA 12/2021
1	Proteins (Proteins, Gene)FDA Link 12/2021
1	Spermine SynthaseIBA 11/2021
1	ProdrugsIBA 11/2021
1	Connexin 43 (Connexin43)IBA 11/2021
1	CalciumIBA 11/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Chemotactic FactorsIBA 01/2021
1	EnzymesIBA 01/2021
1	PLX 4720IBA 01/2021
1	matrigelIBA 01/2021
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 10/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2019
1	benzonidazole (benznidazole)IBA 03/2018
1	Gemcitabine FDA Link 01/2018
1	Granzymes (Granzyme)IBA 10/2017
1	Peptides (Polypeptides)IBA 10/2017
1	AntigensIBA 10/2017
1	A-factor (Streptomyces)IBA 06/2016
1	Chalcone (Benzalacetophenone)IBA 01/2016
1	3-hydroxyflavoneIBA 01/2016
1	Oxidoreductases (Dehydrogenase)IBA 01/2014
1	AminesIBA 01/2014
1	Benzene DerivativesIBA 01/2014
1	DiaminesIBA 07/2013
1	naphthaleneIBA 07/2013
1	butaneIBA 07/2013
1	Cytotoxins (Cytolysins)IBA 12/2009
1	MicronutrientsIBA 02/2008
1	IronIBA 02/2008
1	SiderophoresIBA 02/2008
1	PiperazineIBA 08/2007
1	mycobactinsIBA 09/2004
1	Chelating AgentsIBA 09/2004
1	acinetoferrinIBA 09/2004
1	ImidesIBA 09/2004

Therapy/Procedure

7	Therapeutics 01/2022 - 04/2013
1	Immunotherapy 10/2020